An Artificial Intelligence Model for Intensive Care Length of Stay, Neurological Outcome and Costs Estimation After Cardiopulmonary Resuscitation: a Cohort Study.

September 30, 2025 updated by: Nıgar Kangarlı, Bezmialem Vakif University

AN ARTIFICIAL INTELLIGENCE MODEL FOR INTENSIVE CARE LENGTH OF STAY, NEUROLOGICAL OUTCOME AND COSTS ESTIMATION AFTER CARDIOPULMONARY RESUSCITATION: A COHORT STUDY

The study aims to overview patients registered to Bezmialem Vakıf University Hospital Intensive Care Unit after successive cardiac arrest resuscitation from October 2010 to September 2025. The goal is to determine length of stay in reanimation, neurological clinical outcome and costs of these patients at discharge from the department. All these data is intended to be evaluated by artificial intelligence to evaluate a predictive model.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

5000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients above 18 years after successful cardiopulmonary resuscitation with ROSC registered at Bezmialem Vakıf University Hospital Intensive care unit from October 2010 to September 2025 will be included in the resesarch.

Description

Inclusion Criteria:

  • age>18 years
  • successive cardiopulmonary resuscitation
  • at least 1 hour long admission to ICU after Return Of Spontaneous Circulation (ROSC)

Exclusion Criteria:

  • age < 18 years
  • >80% missing data in patient records
  • patients with no ROSC

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Age >18 years patients after successful cardiopulmonary resuscitation observed in reanimation
Data from patients after successive rescucitaion will be evaluated by machine learning programs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Machine Learning Python programme
Time Frame: 3 months
The created database will be analyzed using a machine learning artificial intelligence algorithm with the Python programming language. After processing missing and incomplete data by artificial intelligence, the database will be divided into two parts: model training and model validation. Meaningful data will be selected through model training, and a prediction model will be built based on these data. To increase the interpretability of the prediction model and help users understand how and why certain predictions are made, the SHapley Additive exPlanations (SHAP) algorithm will be used. In machine learning, the SHAP technique is used to interpret the decision-making processes of complex machine learning models.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2025

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

September 30, 2025

First Submitted That Met QC Criteria

September 30, 2025

First Posted (Estimated)

October 7, 2025

Study Record Updates

Last Update Posted (Estimated)

October 7, 2025

Last Update Submitted That Met QC Criteria

September 30, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Length of ICU Stay

Clinical Trials on no physical or medical interventions

Subscribe